您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > KKL-10
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
KKL-10
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
KKL-10图片
CAS NO:952849-76-2
规格:≥98%
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议
250mg电议
500mg电议

产品介绍
理化性质和储存条件
Molecular Weight (MW) 364.22
Formula C14H10BrN3O2S
CAS No. 952849-76-2
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)DMSO:> 10mM
Water: N/A
Ethanol: N/A
Chemical Name 5-bromo-N-(5-(p-tolyl)-1,3,4-oxadiazol-2-yl)thiophene-2-carboxamide
Synonyms KKL10; KKL 10; KKL-10
SMILES Code O=C(C1=CC=C(Br)S1)NC2=NN=C(C3=CC=C(C)C=C3)O2
实验参考方法
In Vitro

In vitro activity: KL-10 is a small-molecule ribosome rescue inhibitor that possesses a broad-spectrum of antimicrobial activity against bacteria. KKL-10 exhibited exceptional antimicrobial activity against both attenuated and fully virulent strains of F. tularensis in vitro and during ex vivo infection. Addition of KKL-10 to macrophages or liver cells at any time after infection by F. tularensis prevented further bacterial proliferation. When macrophages were stimulated with the proinflammatory cytokine gamma interferon before being infected by F. tularensis, addition of KKL-10 reduced intracellular bacteria by>99%, indicating that the combination of cytokine-induced stress and a nonfunctional ribosome rescue pathway is fatal to F. tularensis. KKL-10 was not cytotoxic to eukaryotic cells in culture. Therefore, KKL-10 is a good lead compound for antibiotic development.


Kinase Assay: For MIC assays, triplicate 2-fold serial dilutions of each compound were made in cation-adjusted Mueller-Hinton broth (CAMHB) and added to a 96-well microtiter plate. Stocks of each compound were prepared in 100% dimethyl sulfoxide (DMSO). Overnight cultures of LVS or Schu S4 were diluted to an OD600 of 0.05 in CAMHB to a final volume of 0.1 ml and added directly to the diluted compounds. The microtiter plates were incubated overnight (~18 h) at 37°C in a humidified incubator with 5% CO2. Bacterial growth was monitored by measuring the optical density at 600 nm. The MIC was determined by observing the lowest concentration at which the compound prevented a significant increase in the optical density. To enumerate F. tularensis after exposure to various concentrations of KKL-10 or KKL-40, the contents of the MIC assay microtiter plate were removed and plated on chocolate agar at appropriate dilutions. After incubation for 48 h at 37°C and 5% CO2, colonies were counted to calculate CFU per milliliter.


Cell Assay: Cytotoxicity assays were performed using RAW 264.7 cells and a lactate dehydrogenase (LDH) release assay kit (Pierce Biochemicals, USA) following the manufacturer's instructions.

In VivoThe hind legs of euthanized C57 mice were skinned and removed at the hip joint, and feet and excess muscle tissue were removed. Marrow was liberated by removing the femurs proximal to each joint and crushing them in a 70-μm nylon mesh filter in 5 ml phosphate-buffered saline (PBS) using a sterile pestle. The marrow was added to conical tubes and centrifuged at 400 × g for 10 min at room temperature. The supernatant was discarded, and the pellet was resuspended in Dulbecco's modified Eagle medium (DMEM) (ThermoFisher, USA). The cells were plated in 100-mm petri dishes at a density of 4 × 105 cells/ml in 10 ml complete macrophage differentiation medium (DMEM plus 20% L929 cell supernatant containing macrophage colony-stimulating factor [M-CSF]). The cells were supplemented with an additional 5 ml of medium on days 1 and 3, and bone marrow-derived macrophages (BMDMs) were harvested on day 7.
Animal model C57 mice
Formulation & Dosage
References Antimicrob Agents Chemother. 2016 May 23;60(6):3276-82.